companies / calderatx-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
Caldera Therapeutics, Inc. was listed in Atlas Venture's portfolio, recorded 2026-09-30.
verified=2026-10-03 json
| total_raised | 37,500,00037.5M | D |
|---|---|---|
| founded | 2025 | |
| hq | Cambridge, Massachusetts | |
| industry | unknown | |
| stage | null |
Caldera Therapeutics is a clinical-stage biotech developing the first-in-class bispecific antibody CLD-423 for inflammatory bowel disease and other inflammatory conditions. It targets patients and clinicians facing IBD that has plateaued on single-target therapies. Its differentiator is hitting two validated pathways, IL-23p19 and TL1A, in one molecule.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2026-01-08 | Funding round | 37,500,00037.5M | null | D |
| person | role | src |
|---|---|---|
| Aaron Royston | director | D |
| Michael Gladstone | director | D |
| Michelle Doig | director | D |
| Praveen Tipirneni | director | D |
| Praveen Tipirneni | executive | D |
| Xiaodi Su | director | D |
| investor | src |
|---|---|
| Atlas Venture | ○ |
Typekit, Adobe Fonts, Afterpay, Sentry, Spin.js, Squarespace, Squarespace Commerce, Stimulus, parallax.js, web-vitals, moment 0, @sentry/browser
| fact | status | src |
|---|---|---|
| Funding round, $37.5M | sourced | D |
| Investor Atlas Venture | sourced | WEB |
| existence | sourced | WEB |
| description | self-reported | WEB |
| date | fact | change | src |
|---|---|---|---|
| 2026-10-03provenance_existence: self-reported → sourced, WEB 2026-10-03 | provenance_existence | self-reported → sourced | WEB 2026-10-03 |
| 2026-09-30provenance_investor_atlas_venture: unknown → sourced, WEB 2026-09-30 | provenance_investor_atlas_venture | unknown → sourced | WEB 2026-09-30 |
| 2026-09-25latest_round: seed, $37.5M, 2026-01-08 → Funding round, $37.5M, 2026-01-08, D 2026-09-25 | latest_round | seed, $37.5M, 2026-01-08 → Funding round, $37.5M, 2026-01-08 |
| D 2026-09-25 |
| 2026-09-25provenance_round: attributed → sourced, D 2026-09-25 | provenance_round | attributed → sourced | D 2026-09-25 |
Records begin 2026-09-24. all_changes